Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 1463 entries
View as:

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06070636 Org: User:
Start: 05/20/24 End: 06/30/25 Due: 06/30/26

Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03674294 Org: User:
Start: 08/04/15 End: 06/01/20 Due: 06/01/21

Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06434090 Org: User:
Start: 06/05/24 End: 07/01/26 Due: 07/01/27

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06587802 Org: User:
Start: 03/14/25 End: 03/14/27 Due: 03/14/28

Secondary Intraocular Lens Implantation in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03240796 Org: User:
Start: 08/01/17 End: 12/31/19 Due: 12/31/20

Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study

Phase: N/A Priority: Normal
NCT ID: NCT04429139 Org: User:
Start: 02/01/11 End: 05/30/20 Due: 05/30/21

Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg

Phase: N/A Priority: Normal
NCT ID: NCT01017679 Org: User:
Start: 05/31/09 End: 12/31/13 Due: 12/31/14

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03151161 Org: User:
Start: 12/31/15 End: 05/31/19 Due: 05/31/20

Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)

Phase: N/A Priority: Normal
NCT ID: NCT05848102 Org: User:
Start: 12/23/22 End: 04/23/25 Due: 04/23/26

Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04936295 Org: User:
Start: 06/16/21 End: 06/01/25 Due: 06/01/26

Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00844454 Org: User:
Start: 05/31/08 End: 05/31/11 Due: 05/31/12

The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05493020 Org: User:
Start: 11/24/22 End: 07/30/23 Due: 07/30/24

Resection+Highly Purified CTL Versus Resection Alone for HCC

Phase: N/A Priority: Normal
NCT ID: NCT02709070 Org: User:
Start: 03/31/16 End: 03/31/22 Due: 03/31/23

TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06301165 Org: User:
Start: 03/19/24 End: 12/31/28 Due: 12/31/29

Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure)

Phase: N/A Priority: Normal
NCT ID: NCT05773391 Org: User:
Start: 04/12/23 End: 08/31/24 Due: 08/31/25

Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

Phase: N/A Priority: Normal
NCT ID: NCT02958592 Org: User:
Start: 06/30/15 End: 10/31/16 Due: 10/31/17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02633176 Org: User:
Start: 01/31/15 End: - Due: -

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT05975307 Org: User:
Start: 12/01/23 End: 12/31/29 Due: 12/31/30

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase: N/A Priority: Normal
NCT ID: NCT03321890 Org: User:
Start: 03/07/17 End: 12/31/20 Due: 12/31/21

Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06367049 Org: User:
Start: 06/01/23 End: 03/01/24 Due: 03/01/25

Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05965531 Org: User:
Start: 01/01/24 End: 12/31/28 Due: 12/31/29

Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

Phase: N/A Priority: Normal
NCT ID: NCT04682249 Org: User:
Start: 12/01/20 End: 02/01/21 Due: 02/01/22

Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma

Phase: N/A Priority: Normal
NCT ID: NCT06429397 Org: User:
Start: 05/01/25 End: 05/28/27 Due: 05/28/28

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04974944 Org: User:
Start: 07/30/21 End: 12/31/24 Due: 12/31/25

Efficacy and Safety of Tocilizumab for TAO

Phase: N/A Priority: Normal
NCT ID: NCT06087731 Org: User:
Start: 09/23/23 End: 09/23/23 Due: 09/23/24